AllyWorth Regulatory Solution (AllyWorth) has a strong leadership management team having professionals with more than 12 to 18 years of relevant experience in Life Sciences, Healthcare, and Pharmaceutical industries to manage the Drug Safety, Pharmacovigilance, and Scientific Medical Writing activities.

Our team of Subject Matter Experts have a decade of pertinent expertise with a commendable performance history in service industry including Clinical Research Organisation (CRO), Knowledge Process Outsourcing (KPO), and Consulting Organisation to manage the Drug Safety, Pharmacovigilance, and Scientific Medical Writing services.

In our history, we take pride for a trustworthy track record, having undergone multiple client audits and regulatory inspections (i.e., USFDA, EMEA, MHRA, Health Canada, TGA, ANVISA, DCGI, Saudi FDA, Egypt MoH, TMDA etc.) with zero critical observations and no instances of repeat observations. We are recognized for establishing a robust Quality Management System that is consistently prepared to undergo unexpected or unannounced regulatory inspections at any time.

AllyWorth has a network of over 500+ physicians, disease specialist, and other healthcare professionals, who serves as pharmacovigilance professionals and medical writers in more than 20 countries across the globe.

AllyWorth has a large network to provide Drug Safety, Pharmacovigilance, and Scientific Medical Writing services in multiple countries worldwide, including but not limited to USA, EU Region, UK, Canada, Australia, Brazil, India, Malaysia, South Korea, North Korea, Middle East and North Africa (MENA) Countries (Algeria, Bahrain, Egypt, Iraq, Iran, Israel, Jordan, Kuwait, Lebanon, Libya, Morocco, Oman, Palestine, Qatar, Saudi Arabia, Sudan, Syria, Tunisia, United Arab Emirates, and Yemen), CIS Countries (Russia, Ukraine, Uzbekistan, Kazakhstan, Kyrgyzstan, Turkmenistan, Tajikistan, Azerbaijan, Armenia, Georgia, Moldova, and Belarus.), African Countries (South Africa, Tanzania, Kenya) etc.